June 8, 2020
Single Use Support celebrates entering the Indian market with their local partners PharmNXT BiotechReading time: 2 minutes
One of the most renowned biopharmaceutical companies in India orders the complete product range of the start-up company Single Use Support based in Austria. The large order associated with this not only opens up the emerging Indian biopharma market, but also underlines the growing relevance of holistic process solutions.
With its developed technologies, the Tyrolean start-up company Single Use Support GmbH is bringing about an important evolutionary step in the biopharma industry, as it is the first to offer holistic solutions for handling liquid pharmaceuticals: from protection in so-called single-use bags to fully automatic filling and freezing, refrigerated transport, thawing and emptying of the drugs. This specially developed process called BULK.STREAM® is the company’s hobby horse and stands out on the market thanks to its coordinated systems and process steps.
An Indian biopharma giant has now ordered the complete product portfolio and thus established the BULK.STREAM® together with the comprehensive technologies for the production of cancer and diabetes therapies. After major orders have already been implemented in large parts of Europe, the USA and China, SUSupport is conquering another promising market with India.
Single Use Support closes the gap in biopharma industry
The fully automated RoSS.FILL filling system is used for sterile filling of liquid substances in single-use bags. Up to 20 bags can be filled in parallel with a total volume of up to 200 liters within a very short time. The Freeze-Thaw platform, in turn, is a system that guarantees controlled freezing and thawing of the intermediates. In addition, the high-quality substances of the pharmaceutical manufacturers can be transported safely, sterile and frozen around the world with the help of transport containers from Single Use Support. With its product innovations and BULK.STREAM®, the innovative start-up company closes a technological gap in the biopharmaceutical industry.
“The risk of product loss is reduced if all technologists are from a single source. With complete solutions, we can increase patient safety and minimize the risk of bio-contamination.” says Johannes Kirchmair, co-founder of Single Use Support, proud of the order from India.
Ambitious growth plans
Due to the constantly increasing demand and the increased internationalization, the start-up company shows constant growth. “We currently employ just over 30 people at the headquarters in Kufstein. The number of employees is planned to increase to 40 by the end of the year.” says Thomas Wurm, co-founder of Single Use Support, an outlook on the further planned growth. “We are looking for both young professionals and experienced professionals, for example from the fields of electrical engineering, automation, engineering and project management as well as IT and business management – ideally with international experience”.
Photos may be used free of charge if the copyright ©Single Use Support is given.